Zacks Highlights 42% EPS Outlook, but MasTec's Risk-Reward Remains Stretched

What happened

Zacks Investment Research published a bullish article on MasTec on October 6, 2026, emphasizing its 42% EPS growth outlook for 2026, attributing it to record backlog, broad infrastructure demand, and stronger profitability across segments. This aligns with the company's existing 2025 guidance of $14.1B revenue, $1.14B adjusted EBITDA, and $6.40 adjusted EPS, which the market has already priced in, with shares up 47% over the past year to $215.99. However, the DeepValue master report rates MTZ a 'POTENTIAL SELL' at current levels due to ~51x trailing EPS, ~21x EV/EBITDA, and a mid-single-digit ROE that leaves little margin for error. Crucially, the article does not address key risks: 48-54% of backlog is cancellable master service agreements, free cash flow was only $20M in Q3 2025 despite strong earnings, and margins still trail peer Quanta by a wide margin. In short, the Zacks piece reiterates the positive narrative already embedded in the stock price, providing no new evidence to justify paying a premium multiple.

Implication

Over a 5-year horizon, MasTec's growth could deliver solid returns if it executes on grid, clean energy, and LNG projects, but investors must demand evidence of sustained margin expansion and positive free cash flow. Today's price already assumes smooth execution and continued backlog growth, leaving little upside if any of the base-case assumptions falter. A more attractive entry would be near $175, while trimming above $230 may be prudent. Until MasTec demonstrates it can close the profitability gap with Quanta and convert earnings to cash, the risk-reward favors patience.

Thesis delta

The Zacks article is promotional and adds no new fundamental information; it simply repeats the bullish case already reflected in the stock's 47% run-up. Our DeepValue thesis stands: the stock is overvalued relative to its current earnings power and cash flow, with risks from cancellable backlog and execution shortfalls. No change to rating or target; if anything, heightened bullish sentiment increases the risk of a valuation correction.